Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-141,822
Closed -$753K 1850
2025
Q1
$753K Sell
141,822
-30,247
-18% -$207K 0.01% 1094
2024
Q4
$1.45M Buy
172,069
+8,327
+5% +$64.3K 0.02% 859
2024
Q3
$1.29M Buy
163,742
+41,754
+34% +$376K 0.02% 833
2024
Q2
$1.26M Buy
121,988
+8,640
+8% +$93.6K 0.02% 778
2024
Q1
$1.42M Buy
113,348
+8,565
+8% +$111K 0.03% 725
2023
Q4
$1.61M Buy
104,783
+9,408
+10% +$131K 0.04% 592
2023
Q3
$1.4M Buy
95,375
+7,742
+9% +$121K 0.04% 553
2023
Q2
$1.55M Buy
+87,633
New +$1.49M 0.05% 495

Other funds holding TBI

Empowered Funds's TBI Position: Q2 2025 in Review

Empowered Funds sold out of Trueblue (TBI) in Q2 2025, closing a stake of 141,822 shares — an estimated $753K sold.

Empowered Funds first reported a position in TBI in Q2 2023 and held it in 8 quarters. The position peaked at $1.61M in Q4 2023. 111 funds tracked by Wall St. Rank hold TBI as of Q2 2025.

  • Empowered Funds reported no remaining Trueblue position as of Q2 2025 after selling out during the quarter.
  • Empowered Funds sold 141,822 Trueblue shares in Q2 2025, an estimated $753K.
  • Empowered Funds first reported a position in Trueblue in Q2 2023 and held it in 8 quarters.
  • Empowered Funds's Trueblue position peaked at $1.61M in Q4 2023.
  • 111 funds tracked by Wall St. Rank held Trueblue as of Q2 2025.

Based on Empowered Funds's 13F filing for Q2 2025, filed 11 Aug 2025.